Moderna « Search Results « Science and Enterprise

CEPI Funds Multi-Variant Covid-19 Vaccine

By Alan, on December 13th, 2021%

Coalition for Epidemic Preparedness Innovations or CEPI is funding a new vaccine to protect against emerging Covid-19 variants and other coronaviruses. . . . → Read More: CEPI Funds Multi-Variant Covid-19 Vaccine

Messenger RNA Developer ETF Launches

By Alan, on December 9th, 2021%

A new exchange traded fund or ETF is underway for individuals to invest in companies developing vaccines or therapies with messenger RNA. . . . → Read More: Messenger RNA Developer ETF Launches

Samsung, Biotech Partner on mRNA Vaccine Production

By Alan, on November 24th, 2021%

A developer of synthetic RNA products is partnering with Samsung Biologics to manufacture Covid-19 vaccines made with messenger RNA. . . . → Read More: Samsung, Biotech Partner on mRNA Vaccine Production

Joint Venture to Develop Stable RNA Covid-19 Vaccine

By Alan, on November 8th, 2021%

A developer of synthetic bio-based products from engineered yeast cells is joining with an immunotherapy drug maker to produce a stable RNA Covid-19 vaccine. . . . → Read More: Joint Venture to Develop Stable RNA Covid-19 Vaccine

Book Review – The Premonition: A Pandemic Story

By Alan, on October 25th, 2021%

As the world struggles to overcome the Covid-19 pandemic, author Michael Lewis tells how the U.S. first struggled to identify and contain the virus. . . . → Read More: Book Review – The Premonition: A Pandemic Story

Covid-19 Nasal Spray Vaccine Trial Underway

By Alan, on September 27th, 2021%

A clinical trial testing the safety of a Covid-19 vaccine from an engineered virus found in dogs and given as a nasal spray enrolled its first participant. . . . → Read More: Covid-19 Nasal Spray Vaccine Trial Underway

CEPI Funding Covid-19 Variant Vaccine

By Alan, on August 19th, 2021%

A biotechnology company is advancing a vaccine to protect against disease from SARS-CoV-2 variants, with new support from the organization CEPI. . . . → Read More: CEPI Funding Covid-19 Variant Vaccine

Biotech Opens Gene Therapy Manufacturing Facility

By Alan, on July 23rd, 2021%

A biotechnology company serving gene therapy developers is opening a manufacturing facility for engineered viruses that deliver gene therapies. . . . → Read More: Biotech Opens Gene Therapy Manufacturing Facility

$60M Challenge Seeks RNA Bio-Production Network

By Alan, on July 14th, 2021%

A new challenge competition aims to build a distributed network of facilities to design, develop, and manufacture RNA-based biologic products. . . . → Read More: $60M Challenge Seeks RNA Bio-Production Network

Low Cost Vaccine, Patch Device Produce Immune Responses

By Alan, on June 3rd, 2021%

Tests with lab mice show one dose of a lower cost Covid-19 vaccine given with a needle-free patch generates strong antibody and cellular immune responses. . . . → Read More: Low Cost Vaccine, Patch Device Produce Immune Responses

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise